Zinc aspartate suppresses T cell activation in vitro and relapsing experimental autoimmune encephalomyelitis in SJL/J mice

BioMetals

Volumn 25, Issue 3, 2012, Pages 529-539

  Stoye, Diana ^a   Schubert, Claudia ^a   Goihl, Alexander ^a   Guttek, Karina ^a   Reinhold, Annegret ^a   Brocke, Stefan ^b   Grüngreiff, Kurt ^c   Reinhold, Dirk ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c Germany   (Germany)

Author keywords

Experimental autoimmune encephalomyelitis (EAE); IL 10; IL 17; IL 2; T cell proliferation; Zinc aspartate

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; TRACE ELEMENT; UNCLASSIFIED DRUG; UNIZINK; ZINC; ZINC ASPARTATE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; DRUG TARGETING; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; RELAPSE; SPLEEN CELL; SUPPLEMENTATION; SWISS JAMES LAMBERT MOUSE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL;

ANIMALIA; MUS;

EID: 84864913192     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-012-9532-z     Document Type: Article

References (49)

1. Bettelli E, Oukka M, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8(4):345-350. doi:10.1038/ni0407-345
2. Biton A, Ansorge S, Bank U, Täger M, Reinhold D, Brocke S (2011) Divergent actions by inhibitors of DP IV and APN family enzymes on CD4? Teff cell motility and functions. Immunobiology 216(12):1295-1301
3. Bray TM, Bettger WJ (1990) The physiological role of zinc as an antioxidant. Free Radic Biol Med 8(3):281-291
4. Brocke S, Quigley L, McFarland HF, Steinman L (1996) Isolation and characterization of autoreactive T cells in experimental autoimmune encephalomyelitis of the mouse. Methods 9(3):458-462
5. Cakman I, Kirchner H, Rink L (1997) Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J Interferon Cytokine Res 17(8):469-472
6. Campo CA, Wellinghausen N, Faber C, Fischer A, Rink L (2001) Zinc inhibits the mixed lymphocyte culture. Biol Trace Element Res 79(1):15-22. doi:10.1385/BTER:79:1:15
7. Chang KL, Hung TC, Hsieh BS, Chen YH, Chen TF, Cheng HL (2006) Zinc at pharmacologic concentrations affects cytokine expression and induces apoptosis of human peripheral blood mononuclear cells. Nutrition 22(5): 465-474. doi:10.1016/j.nut.2005.11.009
8. Codarri L, Gyülvészi G, Tosevski V, Hesske L, Fontana A, Magnenat L, Suter T, Becher B (2011) RORct drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 12(6):560-567. doi: 10.1038/ni.2027
9. Dyment DA, Ebers GC, Sadovnick AD (2004) Genetics of multiple sclerosis. Lancet Neurol 3(2):104-110. doi: 10.1016/S1474-4422(03)00663-X
10. El-Behi M, Ciric B, Dai H, Yan Y, Cullimore M, Safavi F, Zhang GX, Dittel BN, Rostami A (2011) The encephalitogenicity of T(H)17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 12(6):568-575. doi:10.1038/ni.2031
11. Faber C, Gabriel P, Ibs KH, Rink L (2004) Zinc in pharmacological doses suppresses allogeneic reaction without affecting the antigenic response. Bone Marrow Transplant 33(12):1241-1246. doi:10.1038/sj.bmt.1704509
12. FlemingKK, Bovaird JA,MosierMC, EmersonMR, LeVine SM, Marquis JG(2005)Statistical analysis of data fromstudies on experimental autoimmune encephalomyelitis. J Neuroimmunol 170(1-2):71-84. doi:10.1016/j.jneuroim.2005. 08.020
13. Fosmire GJ (1990) Zinc toxicity. Am J Clin Nutr 51(2):225-227
14. Fukada T, Yamasaki S, Nishida K, Murakami M, Hirano T (2011) Zinc homeostasis and signaling in health and diseases: zinc signaling. J Biol Inorg Chem 16(7):1123-1134. doi:10.1007/s00775-011-0797-4
15. Haak S, Croxford AL, Kreymborg K, Heppner FL, Pouly S, Becher B, Waisman A (2009) RORct drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. J Clin Invest 119(1):61-69. doi:10.1172/JCI35997
16. Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP (2006) Immunopathogenesis and immunotherapy of multiple sclerosis. Nat Clin Pract Neurol 2(4):201-211. doi: 10.1038/ncpneuro0154
17. Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, Toyka KV, Gold R (2005) Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 237(2):123-130. doi: 10.1016/j.cellimm.2005.11.002
18. Hofstetter HH, Toyka KV, Tary-Lehmann M, Lehmann PV (2007) Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J Immunol 178(3):1372-1378
19. Ibs KH, Rink L (2003) Zinc-altered immune function. J Nutr 133(5 Suppl 1):146S-1452S
20. Kaltenberg J, Plum LM, Ober-Blöbaum JL, Hönscheid A, R nk L, Haase H (2010) Zinc signals promote IL-2-dependent proliferation of T cells. Eur J Immunol 40(5):1496-1503. doi:10.1002/eji.200939574
21. Keen CL, Gershwin ME (1990) Zinc deficiency and immune function. Annu Rev Nutr 10:415-431. doi:10.1146/ annurev.nu.10.070190.002215
22. Kitabayashi C, Fukada T, Kanamoto M, Ohashi W, Hojyo S, Atsumi T, Ueda N, Azuma I, Hirota H, Murakami M, Hirano T (2010) Zinc suppresses Th17 development via inhibition of STAT3 activation. Int Immunol 22(5): 375-386. doi:10.1093/intimm/dxq017
23. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177(1):566-573
24. Leopold IH (1981) United States Patent 4,255,419
25. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343(13):938-952
26. Penkowa M, Hidalgo J (2000) Metallothionein I ? II expression and their role in experimental autoimmune encephalomyelitis. Glia 32(3):247-263. doi:10.1002/1098-1136(200 012)32:3\247:AID-GLIA50[3.0.CO;2-T
27. Porter KG, McMaster D, Elmes ME, Love AH (1977) Anaemia and low serum-copper during zinc therapy. Lancet 2(8041):774. doi:10.1016/S0140-6736(77) 90295-1
28. Prasad AS (1998) Zinc and immunity. Mol Cell Biochem 188(1-2):63-69. doi:10.1023/A:1006868305749
29. Prasad AS (2000) Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis 182(Suppl 1):S62-S68. doi: 10.1086/315916
30. Prasad AS, Brewer GJ, Schoomaker EB, Rabbani P (1978) Hypocupremia induced by zinc therapy in adults. JAMA 240:2166-2168
31. Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH (2004) Antioxidant effect of zinc in humans. Free Radic Biol Med 37(8):1182-1190. doi:10.1016/j. freeradbiomed.2004.07.007
32. Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, Cardozo LJ (2007) Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85:837-844
33. Reinhold D, Ansorge S, Grüngreiff K (1997) Zinc regulates DNA synthesis and IL-2, IL-6 and IL-10 production of PWM-stimulated PBMC and normalizes the periphere cytokine concentration in chronic liver disease. J Trace Elem Exp Med 10:19-27. doi:10.1002/(SICI)1520-670X(1997)10:1\19:AID- JTRA3[3.0.CO;2-#
34. Reinhold D, Ansorge S, Grüngreiff K (1999) Immunobiology of zinc and zinc therapy. Immunol Today 20(2):102-103. doi: 10.1016/S0167-5699(98)01400-5
35. Reinhold D, Bank U, Entz D, Goihl A, Stoye D, Wrenger S, Brocke S, Thielitz A, Stefin S, Nordhoff K, Heimburg A, Täger M, Ansorge S (2011) PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N(APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice. Biol Chem 392(3):233-237. doi: 10.1515/BC.2011.024
36. Rink L, Haase H (2007) Zinc homeostasis and immunity. Trends Immunol 28(1):1-4. doi:10.1016/j.it.2006.11.005
37. Röhn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, Kopf M, Bachmann MF (2006) Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 36(11):2857-2867. doi:10.1002/eji.200636658
38. Schiffer RB, Herndon RM, Eskin T (1990) Effects of altered dietary trace metals upon experimental allergic encephalomyelitis. Neurotoxicology 11(3):443-450
39. Steinbrecher A, Reinhold D, Quigley L, Gado A, Tresser N, Izikson L, Born I, Faust J, Neubert K, Martin R, Ansorge S, Brocke S (2001) Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. J Immunol 166(3): 2041-2048
40. Steinman L (2007) A brief history of T(H)17, the first majorrevision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13(2):139-145. doi:10.1038/ nm1551
41. Uciechowski P, Kahmann L, Plümäkers B, Malavolta M, Mocchegiani E, Dedoussis G, Herbein G, Jajte J, Fulop T, Rink L (2008) TH1 and TH2 cell polarization increases with aging and is modulated by zinc supplementation. Exp Gerontol 43(5):493-498. doi:10.1016/j.exger.2007.11.006
42. Uyttenhove C, Van Snick J (2006) Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J Immunol 36(11):2868 2874. doi: 10.1002/eji.200636662
43. Varin A, Larbi A, Dedoussis GV, Kanoni S, Jajte J, Rink L, Monti D, Malavolta M, Marcellini F, Mocchegiani E, Herbein G, Fulop T Jr (2008) In vitro and in vivo effects of zinc on cytokine signalling in human T cells. Exp Gerontol 43(5):472-482. doi:10.1016/j.exger.2007.12.008
44. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM (2006) Th17 an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24(6):677-688. doi: 10.1016/j.immuni.2006.06.002
45. Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821-852. doi: 10.1146/annurev.immunol.25.022106.141557
46. Wellinghausen N, Rink L (1998) The significance of zinc for leukocyte biology. J Leukoc Biol 64(5):571-577
47. Wellinghausen N, Kirchner H, Rink L (1997) The immunobiology of zinc. Immunol Today 18(11):519-521. doi: 10.1016/S0167-5699(97)01146-8
48. Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, Sato E, Kurosaki T, Yamashita S, Tokunaga M, Nishida K, Hirano T (2007) Zinc is a novel intracellular second messenger. J Cell Biol 177(4):637-645. doi:10.1083/jcb. 200702081
49. Yu M, Lee WW, Tomar D, Pryshchep S, Czesnikiewicz-GuzikM, Lamar DL, Li G, Singh K, Tian L, Weyand CM, Goronzy JJ (2011) Regulation of T cell receptor signaling by activation-induced zinc inf lux. J Exp Med 208(4):775-785.doi:10. 1084/jem.20100031